Enter inventor name

Timothy J Cardozo

USPTO Granted Patents = 14 (Patent Applications = 3)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 17(Granted Patents)

Company Filing History:

University of Massachusetts

Johns Hopkins University

patents

5. 1 out of 3,539

The United States of America, As Represented by the Secretary, Department of Health and Human Services

patents

6. 1 out of 894

The United States Government As Represented by the Department of Veterans Affairs

patents

where one patent can have more than one assignee

Years Active: 2006-2024

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12162910 - Recombinant gp120 protein with V1-loop deletion (2024-12-10),

2. 11897921 - Propeptide fusion comprising a mutated clostridium botulinum neurotoxin and a VHH domain (2024-02-13),

3. 11787840 - Compositions and methods for treating and preventing autoimmune induced cardiac long QT syndrome (2023-10-17),

4. 11396505 - Inhibitors of CaMKK2 and uses of same (2022-07-26),

5. 9969782 - Highly immunogenic peptides derived from the human immunodeficiency virus V2 region (2018-05-15),

6. 9873661 - Small molecule malarial Aldolase-TRAP enhancers and glideosome inhibitors (2018-01-23),

7. 9611294 - Peptides mimicking HIV-1 viral epitopes in the V2 loop for the GP120 surface envelope glycoprotein (2017-04-04),

8. 9534020 - Immunogenic polypeptides comprising a modified loop peptide presenting the HIV-1 GP120 3074 mAb epitope and scaffold proteins containing said peptide (2017-01-03),

9. 9261497 - Method of treating cancer with modulators of SCFSkp2 (2016-02-16),

10. 9216180 - Pharmaceutical compositions and treatment of genetic diseases associated with nonsense mediated RNA decay (2015-12-22),

11. 9198891 - Method of treating cancer by inhibition of protein kinase-like endoplasmic reticulum protein kinase (2015-12-01),

12. 8961987 - Immunogen comprising the HIV GP120 V3 loop in a conformation that induces broadly neutralizing antibodies (2015-02-24),

13. 7638319 - Method for determining co-receptor selectivity of Human Immunodeficiency Virus-1 (2009-12-29),

14. 7026301 - Method of orally treating inflammatory skin conditions with prodrugs of 5-fluorouracil (2006-04-11),

Title: The Innovations of Timothy J Cardozo

Introduction

Timothy J Cardozo, based in New York, NY, is a distinguished inventor with a substantial portfolio of 14 patents. His work primarily focuses on advancements in the field of biomedicine, particularly regarding HIV treatments and neurotoxins.

Latest Patents

Among his latest innovations is the patent for a recombinant gp120 protein with a V1-loop deletion. This invention discloses embodiments of recombinant HIV-1 gp120 proteins that contain a V1 deletion, alongside gp140, gp145, and gp160 proteins. These proteins, along with the nucleic acid molecules encoding them, can generate an immune response to HIV-1, aiding in the treatment or prevention of HIV-1 infections.

Another notable patent is the development of a propeptide fusion comprising a mutated Clostridium botulinum neurotoxin and a VHH domain. This invention presents a fusion protein linked by a disulfide bond between the light and heavy chain regions of a Clostridial neurotoxin, complemented by a single-chain antibody that boasts antigen-binding activity. This breakthrough offers potential therapeutic agents and methods for effective treatment applications.

Career Highlights

Timothy Cardozo has contributed significantly to research and innovation while working in esteemed institutions such as New York University and the University of Massachusetts. These positions have enabled him to focus on creating impactful biomedical solutions, particularly in infectious diseases.

Collaborations

Throughout his career, Cardozo has collaborated with notable professionals in the field, including Susan Zolla-Pazner and Xiang-peng Kong. These partnerships have enhanced the scope and effectiveness of his innovations, yielding patents that contribute to vital health advancements.

Conclusion

With a strong foundation in biomedical research and an impressive array of patents, Timothy J Cardozo continues to demonstrate his commitment to innovation. His work not only furthers scientific understanding but also provides significant potential to improve health outcomes for individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com